03rd December 2021 | Pharma Updates
Biocon gets FDA approval for generic product
The generic product is indicated to adult patients with kidney transplants, and it is available in 180 milligrams and 360 milligrams strengths.
Beximco gets 4.5 mn Covid Vaccine Doses for The Distribution In Bangladesh
Beximco said it has received the Covid vaccines from the Serum Institute of India for its distribution in Bangladesh.
Uttar Pradesh, Bihar among 7 states to be administered ZyCoV-D vaccine first
The seven states of India are Maharashtra, Punjab, Tamil Nadu, Bihar, Uttar Pradesh, Jharkhand and West Bengal.
Lupin buys rights to make TTP inhalation products
Lupin Inc has signed an agreement with TTP Plc to buy rights to develop, manufacture and market inhalation products.
Pharma Industry could make full use of potential in North-East Asian markets
The North-East Asian generic drug market has been valued at more than USD 100 bn.
Pharma Education & Research Amendment Bill, 2021 to be presented in Lok Sabha
The bill will amend the NIPER Act, 1998.
SII seeks DCGI’s nod for Covishield as booster dose
The institute has requested the DCGI because of the emergence of new Covid19 variants.
